Director · Bone Biologics Corp · Bone Biologics Corp — Non-Employee Stock Option
Side
A
Value
—
Shares
113.9K
Price
—
Executed
Sep 28, 2026
Disclosed
Sep 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 28 executedSep 30, 2026 disclosed
BBLG · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gagnon Robert E. filed this Form 4 reporting a grant or award of BBLG on Sep 28, 2026. It became public on Sep 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Gagnon Robert E.cik:0001504983
Issuer
Bone Biologics Corpcik:0001419554
Revision history · 0
No field has changed since this record was first ingested.
